01 1Chongqing Kangle Pharmaceutical
01 1HYDROXYCHLOROQUINE SULFATE USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-06-22
Pay. Date : 2020-06-11
DMF Number : 30825
Submission : 2016-08-01
Status : Active
Type : II
20
Chongqing Kangle Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDROXYCHLOROQUINE SULFATE USP, with a corresponding US DMF Number 30825.
Remarkably, this DMF maintains an Active status since its submission on August 01, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 22, 2020, and payment made on June 11, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
